Related Experiment Video
Updated: Jul 4, 2026
09:16
Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
Structure-based view of epidermal growth factor receptor regulation
1Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. ferguso2@mail.med.upenn.edu
Annual Review of Biophysics
|June 25, 2008
Summary
Recent crystal structures reveal how epidermal growth factor receptor (EGFR) activation occurs through ligand binding, leading to receptor dimerization and kinase activation. This insight impacts understanding of EGFR-driven cancers and potential therapies.
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- The epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases plays a critical role in cellular signaling.
- Dysregulation of EGFR signaling is implicated in various cancers.
- Understanding the precise mechanism of EGFR activation is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent high-resolution X-ray crystal structures of the EGFR family.
- To elucidate the mechanism of ligand-induced receptor activation.
- To discuss the implications of activating tumor mutations on EGFR function and inhibition.
Main Methods:
- Analysis of high-resolution X-ray crystal structures.
- Review of recent structural and biochemical studies on EGFR family members.
Main Results:
- Ligand binding induces significant domain reorganization in the extracellular region of EGFR.
- This reorganization facilitates the formation of a receptor-mediated dimer.
- Intracellular kinase domains form an asymmetric dimer, leading to allosteric kinase activation.
Conclusions:
- Recent structural data provide a detailed view of ligand-induced EGFR activation.
- Activating mutations in EGFR contribute to cancer development.
- Understanding these activation mechanisms is key for developing effective EGFR inhibitors.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...